[Costs and financial feasibility of long-term drug therapy of chronic polyarthritis].
The annual costs of the most common basic therapies in Germany will be analyzed. The costs in Deutsche marks will be divided as drug charges, physician charges and laboratory expenses. There are significant price differences also in equipotent preparations.
Mössinger
F
F
D000893:Anti-Inflammatory Agents / Q000191:economics* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000191:economics*; D003365:Costs and Cost Analysis; D005240:Feasibility Studies; D005858:Germany; D006801:Humans; D008134:Long-Term Care / Q000191:economics
D000893:Anti-Inflammatory Agents
Kosten und Finanzierbarkeit der medikamentösen Langzeittherapie der chronischen Polyarthritis.